Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20034276HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034277HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034280HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047208HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034278HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034282HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034283HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047211HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047209HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034281HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TCGA Plot Options
Drug Information
GeneHTR1D
DrugBank IDDB01238
Drug NameAripiprazole
Target IDBE0000659
UniProt IDP28221
Regulation Typeantagonist
PubMed IDs17848919; 26346901
CitationsNasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11.@@de Bartolomeis A, Tomasetti C, Iasevoli F: Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism. CNS Drugs. 2015 Sep;29(9):773-99. doi: 10.1007/s40263-015-0278-3.
GroupsApproved; Investigational
Direct ClassificationPhenylpiperazines
SMILESClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Pathways
PharmGKBPA10026
ChEMBLCHEMBL1112